Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market, Open Observational Long-term Effectiveness Follow-up Study of Participants With Drug-resistant Epilepsy With Partial-onset Seizures Previously Enrolled in a Randomized Controlled Trial (E-100: PuLsE) Comparing Best Medical Practice With or w/o Adjunctive Vagus Nerve Stimulation Therapy

NCT01281280 is registered in ClinicalTrials.gov with Cyberonics, Inc. as lead sponsor.

NCT NCT01281280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01281280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market, Open Observational Long-term Effectiveness Follow-up Study of Participants With Drug-resistant Epilepsy With Partial-onset Seizures Previously Enrolled in a Randomized Controlled Trial (E-100: PuLsE) Comparing Best Medical Practice With or w/o Adjunctive Vagus Nerve Stimulation Therapy
Lead sponsor
Cyberonics, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
April 30, 2014
Enrollment
81 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy